Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Morgan Stanley analyst Carlos De Alba downgraded Alcoa Corp (NYSE:AA) from Overweight to Equal-Weight and lowered the price target from $79 to $53. Alcoa shares closed at $49.01 on Tuesday. See how other analysts view this stock.
• Baird analyst Eric Coldwell downgraded Medpace Holdings Inc (NASDAQ:MEDP) from Outperform to Neutral and raised the price target from $477 to $547. Medpace shares closed at $546.29 on Tuesday. See how other analysts view this stock.
• B of A Securities analyst Ebrahim Poonawala downgraded Truist Financial Corp (NYSE:TFC) from Buy to Neutral and raised the price target from $54 to $56. Truist Financial shares closed at $51.36 on Tuesday. See how other analysts view this stock.
• Barclays analyst Andrew Mok downgraded HCA Healthcare Inc (NYSE:HCA) from Overweight to Equal-Weight and slashed the price target from $496 to $427. HCA Healthcare shares closed at $423.11 on Tuesday. See how other analysts view this stock.
• Keefe, Bruyette & Woods analyst Meyer Shields downgraded Travelers Companies Inc (NYSE:TRV) from Outperform to Market Perform and raised the price target from $342 to $356. Travelers shares closed at $343.73 on Tuesday. See how other analysts view this stock.

Considering buying HCA stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.